Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

86.5K
Overview
86.5K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

6.0K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
6.0K
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

17.4K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
17.4K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

8.3K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
8.3K
T Cell Types and Functions01:24

T Cell Types and Functions

3.3K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
3.3K
Special Features of Adaptive Immunity01:20

Special Features of Adaptive Immunity

4.5K
The adaptive immune system, a crucial component of the overall immune response, offers a highly specialized defense against pathogens. It involves specific cell types and features, enabling it to combat infections effectively and efficiently.
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
4.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Two-Year Follow-up From the T1GER Study: Continued Off-Therapy Metabolic Improvements in Children and Young Adults With New-Onset T1D Treated With Golimumab and Characterization of Responders.

Diabetes care·2022
Same author

Golimumab and Beta-Cell Function in Youth with New-Onset Type 1 Diabetes.

The New England journal of medicine·2020
Same author

Novel Therapeutic Approaches Targeting the Renin-Angiotensin System and Associated Peptides in Hypertension and Heart Failure.

Pharmacological reviews·2019
Same author

Factors Associated with Survival during High-Frequency Oscillatory Ventilation in Children.

Journal of pediatric intensive care·2019
Same author

Propofol-Based Procedural Sedation with or without Low-Dose Ketamine in Children.

Journal of pediatric intensive care·2019
Same author

Alpha-1 antitrypsin treatment of new-onset type 1 diabetes: An open-label, phase I clinical trial (RETAIN) to assess safety and pharmacokinetics.

Pediatric diabetes·2018

Related Experiment Video

Updated: Apr 3, 2026

High-Efficiency Generation of Antigen-Specific Primary Mouse Cytotoxic T Cells for Functional Testing in an Autoimmune Diabetes Model
11:31

High-Efficiency Generation of Antigen-Specific Primary Mouse Cytotoxic T Cells for Functional Testing in an Autoimmune Diabetes Model

Published on: August 16, 2019

8.6K

Targeting memory T cells in type 1 diabetes.

Mario R Ehlers1, Mark R Rigby2

  • 1Clinical Trials Group, Immune Tolerance Network, 185 Berry Street, Suite 3515, San Francisco, CA, 94107, USA. mehlers@immunetolerance.org.

Current Diabetes Reports
|September 16, 2015
PubMed
Summary

Type 1 diabetes (T1D) involves autoimmune destruction of pancreatic beta cells by memory T cells. Controlling these autoreactive T cells is crucial for preserving beta cell function and transplant success.

Keywords:
AlefaceptAutoimmunityCD2CD3Central memory T cellsCostimulation blockadeEffector memory T cellsHomeostatic cytokines

More Related Videos

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells
06:27

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells

Published on: May 6, 2013

17.5K
Extraction of Tissue Antigens for Functional Assays
08:32

Extraction of Tissue Antigens for Functional Assays

Published on: September 10, 2012

11.4K

Related Experiment Videos

Last Updated: Apr 3, 2026

High-Efficiency Generation of Antigen-Specific Primary Mouse Cytotoxic T Cells for Functional Testing in an Autoimmune Diabetes Model
11:31

High-Efficiency Generation of Antigen-Specific Primary Mouse Cytotoxic T Cells for Functional Testing in an Autoimmune Diabetes Model

Published on: August 16, 2019

8.6K
Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells
06:27

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells

Published on: May 6, 2013

17.5K
Extraction of Tissue Antigens for Functional Assays
08:32

Extraction of Tissue Antigens for Functional Assays

Published on: September 10, 2012

11.4K

Area of Science:

  • Immunology
  • Endocrinology
  • Autoimmunity

Background:

  • Type 1 diabetes (T1D) is a chronic autoimmune condition characterized by the destruction of pancreatic beta cells.
  • Patients with T1D exhibit self-reactive T cells with a memory phenotype in both CD4(+) and CD8(+) compartments.
  • These autoreactive memory T cells are long-lived, highly responsive, and resistant to regulatory mechanisms, contributing to disease progression and transplant rejection.

Purpose of the Study:

  • To highlight the critical role of autoreactive memory T cells in Type 1 diabetes pathogenesis.
  • To discuss the challenges posed by these cells in preserving beta cell function and allogeneic islet transplants.
  • To explore potential therapeutic strategies targeting the autoreactive memory T cell compartment.

Main Methods:

  • Review of existing literature on T cell phenotypes in Type 1 diabetes.
  • Analysis of the characteristics and behavior of autoreactive memory T cells.
  • Evaluation of current and potential immune interventions for T1D.

Main Results:

  • Autoreactive memory T cells (CD4(+) and CD8(+)) are a hallmark of Type 1 diabetes.
  • These cells demonstrate enhanced responsiveness and resistance to suppression, promoting disease persistence.
  • Existing successful immune interventions often target memory T cells.

Conclusions:

  • Effective control of autoreactive memory T cells is essential for preserving residual beta cells in new-onset T1D.
  • Strategies such as depletion or modulation of these T cells are necessary for successful stem cell therapies or transplantation.
  • Future T1D treatments must incorporate approaches to manage the autoreactive memory T cell compartment.